JWCTF (JW (Cayman) Therapeutics Co) Other Long Term Assets : $0.87 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is JW (Cayman) Therapeutics Co Other Long Term Assets?

JW (Cayman) Therapeutics Co's other long-term assets for the quarter that ended in Jun. 2024 was $0.87 Mil.

JW (Cayman) Therapeutics Co's quarterly other long-term assets increased from Jun. 2023 ($2.19 Mil) to Dec. 2023 ($2.41 Mil) but then stayed the same from Dec. 2023 ($2.41 Mil) to Jun. 2024 ($0.87 Mil).

JW (Cayman) Therapeutics Co's annual other long-term assets declined from Dec. 2021 ($2.82 Mil) to Dec. 2022 ($1.70 Mil) but then increased from Dec. 2022 ($1.70 Mil) to Dec. 2023 ($2.41 Mil).

JW (Cayman) Therapeutics Co Other Long Term Assets Historical Data

The historical data trend for JW (Cayman) Therapeutics Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW (Cayman) Therapeutics Co Other Long Term Assets Chart

JW (Cayman) Therapeutics Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

4.08

6.35

2.82

1.70

2.41

JW (Cayman) Therapeutics Co Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Long Term Assets	Get a 7-Day Free Trial							4.24	1.70	2.19	2.41	0.87

JW (Cayman) Therapeutics Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

JW (Cayman) Therapeutics Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » JW (Cayman) Therapeutics Co Ltd (OTCPK:JWCTF) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

02126:Hong Kong JNY:Germany

Address

No. 699 Zhong Ke Road, 5F, Building B, Pudong New District, Shanghai, CHN

Website

https://www.jwtherapeutics.com

JW (Cayman) Therapeutics Co Ltd is a clinical-stage cell therapy company in China. It focuses on developing, manufacturing, and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors. Its lead product candidate is relmacabtagene autoleucel, which is a potential superior anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy intended for the treatment of a range of hematological cancers.

JW (Cayman) Therapeutics Co Headlines

No Headlines